Lurasidone Tablets Generics - Manufacturers & Suppliers
Latuda® (US)
| Product/Composition:- | Lurasidone Tablets |
|---|---|
| Strength:- | 20 mg, 40 mg, 60 mg, 80 mg, 120 mg |
| Form:- | Oral Tablets |
| Reference Brands:- | Latuda® (US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Lurasidone is an atypical antipsychotic that works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, helping to reduce psychotic and mood disorder symptoms. It also has partial agonist activity at 5-HT1A receptors, contributing to mood stabilization. Lurasidone tablets are used to treat schizophrenia and bipolar depression (bipolar I disorder) in adults and adolescents. The medication offers a favorable metabolic profile, making it suitable for long-term use in managing psychiatric conditions.
Lurasidone tablets are FDA-approved in the United States for the treatment of schizophrenia and bipolar depression (bipolar I disorder) in adults and adolescents. In the European Union, Lurasidone is authorized under the brand name Latuda for schizophrenia in adults and adolescents aged 13 years and older, via centralized EMA procedures. Regulatory requirements include GMP-compliant manufacturing, clinical trial data demonstrating efficacy and safety, and documentation addressing metabolic effects, akathisia, and suicidality risks. U.S. submissions must comply with boxed warning requirements, while EMA approval requires Risk Management Plans (RMPs) and ongoing pharmacovigilance. To explore dossier-ready Lurasidone tablets and sourcing options, visit Pharmatradz.com — your trusted B2B pharma partner.